SECONDCELL BIO
Secondcell is about scaling up a validated platform biotechnology with multiple opportunities for carve-off IPO’s & licensing realizing ROI for investors.
The company’s Chromovert® Technology originates from a Nobel-Prize winning laboratory at The Rockefeller University.
Chromovert® is past start-up and ready to scale. $100M+ USD was invested to incubate the tech which is fully privately owned and unencumbered (no VC or U.S. gov’t funds used). Applications include drug discovery, personalized medicine, biologics manufacturing, cell and stem cell therapies, AgriTech including crop engineering and pest control, and more.
We are currently exploring using the technology to create a new biotechnology hub in the UAE. With capital and leadership of the UAE to open new sectors, proprietary disruptive technologies like Chromovert® have the potential to leapfrog global competition and anchor the world’s next best biotechnology hub.
CHROMOVERT® TECHNOLOGY
Chromovert® is a disruptive cellular engineering biotechnology. Biological science deals with the human cell. Cells that exactly mimic human disease are fundamental for discovery of new drugs. However, in a sea of cells engineered to model disease, only a tiny number are suitable. Chromovert® permits the rapid purification of even rare, optimally engineered cells.
Prior validation examples of the multi-use discovery engine include: 1) a novel nonaddictive painkiller discovered using Chromovert® and fast-tracked by the FDA was the subject IPO filing with the U.S. SEC. 2) Chromovert® was also used in strategic natural flavors research with The Coca-Cola Company, Kraft Foods and Nestle resulting in new natural sweeteners and the first-known salty-taste enhancers to cut salt and sugar in the diet.
Company Details
- Employees
- 6
- Address
- Abu Dhabi Executive Office Ministry Of Industry & Advanced Technology | وزارة الصناعة والتكنولوجيا المتقدمة Hub71 G42 M42 Health Mubadala Mubadala Health Advanced Technology Research Council Technology Innovation Institute Khalifa University United Arab Emirates University Cleveland Clinic Abu Dhabi Ministry Of Health And Prevention - Uae Purehealth Seha - Abu Dhabi Health Services Co. Abu Dhabi Stem Cells Center Abu Dhabi & Dubai Global Biotech Committee Adgm Difc Emirates Development Bank (Edb) Uae Genetic Diseases Association
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.secondcellbio.com/
- Keywords
- Drug Discovery, Stable Cell Line, Cell-Based Assay, Drugomics, Cellbraries, Biologics, rAAV, Cell Therapy, pChromo-Plasmids, Chromovert, Chromo-Tags, Stablon, HTS, Cell Engineering, Genetic Engineering.
- Competitors
- AlGenome, UAE & GCC BioTech Community (Join: https://www.linkedin.com/groups/13182208), PSC Biotech Ltd - EU, IND, UK, UAE, Channel Therapeutics, EPYGEN Biotech, Research Foundation for Cure Initiatives, UAE BioTech Symposium, Eastern Biotech & Life Sciences, Hayat Biotech, AmCham Abu Dhabi.
Secondcell Bio Questions
Secondcell Bio's website is https://www.secondcellbio.com/
Secondcell Bio's LinkedIn profile is https://www.linkedin.com/company/secondcellbio
Secondcell Bio has
6 employees.
View email and phone details for 6
employees at Secondcell Bio.
Secondcell Bio's industry is
Pharmaceutical Manufacturing
Secondcell Bio's top competitors are
Algenome,
Uae & Gcc Biotech Community (Join: Https://www.linkedin.com/groups/13182208),
Psc Biotech Ltd - Eu, Ind, Uk, Uae,
Channel Therapeutics,
Epygen Biotech,
Research Foundation For Cure Initiatives,
Uae Biotech Symposium,
Eastern Biotech & Life Sciences,
Hayat Biotech,
Amcham Abu Dhabi.
Secondcell Bio's categories are Pharmaceutical Manufacturing
